LINC00857 and cancer: Our study discovered the pro-carcinogenic effect of LINC00857 in PAAD cancer cells, that is, LINC00857 was implicated in the malignancy of PAAD via acting as a ceRNA competitively targeting to miR-340-5p and thereby upregulating TGFA expression.